Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A3 adenosine receptor
Open Access
- 26 July 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Purinergic Signalling
- Vol. 2 (4), 627-632
- https://doi.org/10.1007/s11302-006-9020-4
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Activation of protein kinase B by adenosine A1 and A3 receptors in newborn rat cardiomyocytesJournal of Molecular and Cellular Cardiology, 2004
- Expression of Hypothalamic–Pituitary–Thyroid Axis RelatedGenes in the Human SkinJournal of Investigative Dermatology, 2002
- Expression of the High-Affinity Choline Transporter, CHT1, in the Neuronal and Non-neuronal Cholinergic System of Human and Rat SkinJournal of Investigative Dermatology, 2002
- Serotoninergic System in Hamster SkinJournal of Investigative Dermatology, 2002
- Activation of A3Adenosine Receptor Protects Against Doxorubicin-induced CardiotoxicityJournal of Molecular and Cellular Cardiology, 2001
- Right Thing at a Wrong Time?. Adenosine A3 Receptors and Cerebroprotection in StrokeAnnals of the New York Academy of Sciences, 2001
- Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptorEuropean Journal Of Cancer, 2000
- Adenosine A3 receptors and viability of astrocytesDrug Development Research, 1998
- The A3Adenosine Receptor Mediates Cell Spreading, Reorganization of Actin Cytoskeleton, and Distribution of Bcl-xL: Studies in Human Astroglioma CellsBiochemical and Biophysical Research Communications, 1997